SARS-CoV-2 hijacks host CD55, CD59 and factor H to impair antibody-dependent complement-mediated lysis

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• The complement system is crucial for innate immunity against pathogens.
• Regulators of Complement Activation (RCAs) prevent excessive complement activity.
• SARS-CoV-2 pathogenesis involves complex host-pathogen interactions.

Purpose of the Study:

• To investigate how SARS-CoV-2 evades antibody-dependent complement-mediated lysis.
• To identify specific host factors utilized by SARS-CoV-2 for immune evasion.
• To explore therapeutic strategies targeting viral complement resistance.

Main Methods:

• Analysis of SARS-CoV-2 interaction with host RCAs (CD55, CD59, Factor H).
• Functional assays assessing complement-mediated lysis of SARS-CoV-2.
• Inhibition studies using blocking antibodies and recombinant proteins.

Main Results:

• SARS-CoV-2 utilizes host CD55, CD59, and Factor H to resist complement lysis.
• Blocking these RCAs restores viral sensitivity to complement-mediated killing.
• Complement-mediated virolysis requires classical pathway activation and virus-specific antibodies.

Conclusions:

• SARS-CoV-2 employs a sophisticated immune escape mechanism by hijacking host RCAs.
• Targeting these viral-host interactions could enhance complement-mediated viral clearance.
• Findings offer insights into COVID-19 immunopathology and potential therapeutic targets.